Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Placebo-controlled Double-blinded Study of the Effect of TOTUM-63 on Glucose and Lipid Homeostasis in Subjects With Dysglycemia

NCT04423302 is registered in ClinicalTrials.gov with Valbiotis as lead sponsor.

NCT NCT04423302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04423302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Placebo-controlled Double-blinded Study of the Effect of TOTUM-63 on Glucose and Lipid Homeostasis in Subjects With Dysglycemia
Lead sponsor
Valbiotis
Phase
Not applicable
Overall status
Completed
Start date
July 8, 2020
Completion date
June 23, 2023
Enrollment
636 (actual)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes type2, dysglycemia, prediabetic state